These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 6815600

  • 1. Promethazine hydrochloride therapy in severely Rh-sensitized pregnancies.
    Charles AG, Blumenthal LS.
    Obstet Gynecol; 1982 Nov; 60(5):627-30. PubMed ID: 6815600
    [Abstract] [Full Text] [Related]

  • 2. The treatment of erythroblastosis with promethazine hydrochloride.
    Gusdon JP.
    J Reprod Med; 1981 Sep; 26(9):454-8. PubMed ID: 7288746
    [Abstract] [Full Text] [Related]

  • 3. [Promethazine in the treatment during pregnancy of severs forms of iso-immunization to Rhesus factor].
    Palliez R, Delecour M, Monnier JC, Begueri F, Leroy PY.
    Bull Fed Soc Gynecol Obstet Lang Fr; 1970 Sep; 22(2):199-201. PubMed ID: 4990805
    [No Abstract] [Full Text] [Related]

  • 4. Rhesus disease: the model for fetal therapy.
    Nicolaides KH, Rodeck CH.
    Br J Hosp Med; 1985 Sep; 34(3):141-8. PubMed ID: 3933599
    [Abstract] [Full Text] [Related]

  • 5. Rh immunization in Manitoba: progress in prevention and management.
    Bowman JM, Pollock J.
    Can Med Assoc J; 1983 Aug 15; 129(4):343-5. PubMed ID: 6409390
    [Abstract] [Full Text] [Related]

  • 6. Rh isoimmunization related to amniocentesis.
    Murray JC, Karp LE, Williamson RA, Cheng EY, Luthy DA.
    Am J Med Genet; 1983 Dec 15; 16(4):527-34. PubMed ID: 6419606
    [Abstract] [Full Text] [Related]

  • 7. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM, Vrijkotte TG, van der Schoot CE, Bonsel GJ, de Haas M.
    Transfusion; 2008 May 15; 48(5):941-52. PubMed ID: 18248570
    [Abstract] [Full Text] [Related]

  • 8. Maternal immunity to red cell antigens and fetal transfusion.
    Gibble JW, Ness PM.
    Clin Lab Med; 1992 Sep 15; 12(3):553-76. PubMed ID: 1521427
    [Abstract] [Full Text] [Related]

  • 9. Diagnosing hemolytic disease of the newborn.
    Brantley TA.
    Clin Lab Sci; 2002 Sep 15; 15(3):140-3. PubMed ID: 12778961
    [Abstract] [Full Text] [Related]

  • 10. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
    Miquel E, Cavelier B, Bonneau JC, Rouger P.
    Transfus Clin Biol; 2005 Feb 15; 12(1):45-55. PubMed ID: 15814293
    [Abstract] [Full Text] [Related]

  • 11. [Initial trials in the treatment of feto-maternal alloimmunization in the Rhesus system with oral administration of erythrocyte antigens].
    Parinaud J, Fournié A, Grandjean H, Blanc M, Pontonnier G.
    J Gynecol Obstet Biol Reprod (Paris); 1983 Feb 15; 12(4):407-13. PubMed ID: 6415152
    [Abstract] [Full Text] [Related]

  • 12. [Prenatal immunological research on hemolytic disease of the newborn].
    Gota F, Dallavalle FM.
    Arch Sci Med (Torino); 1980 Feb 15; 137(4):563-5. PubMed ID: 6788016
    [No Abstract] [Full Text] [Related]

  • 13. Maternal CW alloimmunization.
    Bowman JM, Pollock J.
    Vox Sang; 1993 Feb 15; 64(4):226-30. PubMed ID: 8517051
    [Abstract] [Full Text] [Related]

  • 14. [Antenatal treatment of maternal-fetal Rh incompatibility hemolysis disease].
    Zhao L, Huang X, Wang Q.
    Zhonghua Fu Chan Ke Za Zhi; 1998 Jul 15; 33(7):406-8. PubMed ID: 10806699
    [Abstract] [Full Text] [Related]

  • 15. Role of IVIG in preventing exchange transfusions in Rh hemolytic disease.
    Aylin T, Berkan G.
    Indian Pediatr; 2005 Jan 15; 42(1):77-9. PubMed ID: 15695869
    [No Abstract] [Full Text] [Related]

  • 16. [Prophylaxis of hemolytic disease of newborn].
    Kietlińska-Kmiolek Z.
    Wiad Lek; 1971 Apr 15; 24(8):755-60. PubMed ID: 4996047
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The importance of central care of Rh-sensitized women for the prophylaxis of hemolytic disease of the newborn].
    Holtorff J, Brey J, Nitzsche M.
    Zentralbl Gynakol; 1969 May 17; 91(20):629-47. PubMed ID: 4984542
    [No Abstract] [Full Text] [Related]

  • 20. [Immunosuppressive agents in Rh immunization].
    Onnis A.
    Attual Ostet Ginecol; 1969 May 17; 15(2):89-95. PubMed ID: 4998491
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.